What is atypical lobular hyperplasia?
Atypical lobular hyperplasia is a precancerous condition that generally affects breast tissue. Treatment of this condition usually involves removing any suspicious tissues for further evaluation. Atypical lobular hyperplasia generally considered benign, has the potential to become cancer if it is not treated. Women can reduce the risk of breast cancer by proactive measures. Initially considered benign, this can lead to non -invasive or in situ cancer situ, if abnormal cells continue to mutate and multiply. The term in situ means that cancer remains limited to the original area of abnormal cell development. If it is not treated, non -invasive atypical lobular hyperplasia can become invasive and spread to the surrounding tissues, lymph nodes and blood vessels.
Atypical lobular hyperplasia does not produce any symptoms or symptoms. In general, this form of hyperplasia is detected only during a routine mammogram or during a biopsy. Once the biopsy is completed, it may be during the analysisDisconnecting samples to show evidence of atypical hyperplasia. If atypical hyperplasia is confirmed, surgery may be necessary to remove a large part of the tissue for further analysis to determine whether in situ or invasive cancer is present.
Treatment of atypical hyperplasia generally involves surgery to remove all affected tissue. If tests are negative (benign), regular testing for further screening for breast cancer can be recommended. Women with atypical hyperplasia are recommended to make self -expression every month to check any abnormalities or changes in their breasts. Annual mammograms can also be designed as preventive measures. Those who have a family history of breast cancer can also undergo periodic display tests that may include the use of magnetic resonance imaging (MRI).
women who have genetic predispFor some time, breast cancer will consider the use of preventive drugs such as selective modrogen receptor modulator (SERM) such as tamoxifen. Participation in clinical trials focused specifically in breast cancer prevention in the presence of atypical hyperplasia may also be possible. Those facing extremely high risk of breast cancer development may decide to perform preventive mastectomy, which is surgical removal of both breasts. Due to the correlation between combined hormonal therapy and breast cancer, women who have been diagnosed with atypical lobular hyperplasia should be used to prevent synthetic progestin and estrogen during menopause.
those diagnosed with atypical hyperplase without atypical hyperplasia. Women who are diagnosed at a young age may also be exposed to even greater risk of cancer development. After diagnosis of atypical lobular hyperplasia, women encourage to educate their individualRisk factors for breast cancer to make informed decisions on treatment and approach options. Women may also be encouraged to remain proactive to reduce the risk of cancer and make a choice of a healthy lifestyle, such as maintaining healthy body weight, regular exercise and balanced diet.